VBL Therapeutics Announces Third Quarter 2018 Financial Results
Conference Call and Webcast at 8:30am Eastern Time Today TEL AVIV, Israel, Nov. 20, 2018 (GLOBE NEWSWIRE) — VBL Therapeutics […]
ProQR to Present at the Evercore ISI HealthConX Conference
LEIDEN, the Netherlands, Nov. 20, 2018 (GLOBE NEWSWIRE) — ProQR Therapeutics N.V. (Nasdaq:PRQR), a company dedicated to changing lives through […]
Ovid Therapeutics Announces OV935/TAK-935 Presentations at the American Epilepsy Society 72nd Annual Meeting
NEW YORK, Nov. 20, 2018 (GLOBE NEWSWIRE) — Ovid Therapeutics Inc. (NASDAQ: OVID), a biopharmaceutical company committed to developing medicines […]
Stemline Therapeutics Announces that European Medicines Agency (EMA) Grants Accelerated Assessment for planned ELZONRIS Marketing Authorization Application (MAA)
NEW YORK, Nov. 20, 2018 (GLOBE NEWSWIRE) — Stemline Therapeutics, Inc. (Nasdaq: STML), a biopharmaceutical company focused on the development […]
NuCana to Participate in the 2018 Evercore ISI HealthCONx Conference
EDINBURGH, United Kingdom, Nov. 20, 2018 (GLOBE NEWSWIRE) — NuCana plc (NASDAQ:NCNA), a clinical-stage biopharmaceutical company focused on significantly improving […]
Surface Oncology Announces Upcoming Investor Presentations
CAMBRIDGE, Mass., Nov. 20, 2018 (GLOBE NEWSWIRE) — Surface Oncology (Nasdaq: SURF), a clinical-stage immuno-oncology company developing next-generation immunotherapies that […]
Eloxx Pharmaceuticals To Present at the 30th Annual Piper Jaffray Healthcare Conference on Wednesday, November 28, 2018
WALTHAM, Mass., Nov. 20, 2018 (GLOBE NEWSWIRE) — Eloxx Pharmaceuticals, Inc., (NASDAQ: ELOX) a clinical-stage biopharmaceutical company dedicated to the […]
Apellis Pharmaceuticals Expands Leadership Team, Appoints Adam Townsend as Chief Commercial Officer
CRESTWOOD, Ky. and WALTHAM, Mass., Nov. 20, 2018 (GLOBE NEWSWIRE) — Apellis Pharmaceuticals, Inc., (Nasdaq:APLS) a clinical-stage biopharmaceutical company focused […]
BioCryst Appoints Rare Disease Expert Theresa Heggie to Board of Directors
RESEARCH TRIANGLE PARK, N.C., Nov. 20, 2018 (GLOBE NEWSWIRE) — BioCryst Pharmaceuticals, Inc. (Nasdaq:BCRX) today announced that the company has […]
TSX News -
Calian Announces Its Intention to Make a Normal Course Issuer Bid
(All amounts in this release are in Canadian Dollars) KANATA, Ontario, Nov. 20, 2018 (GLOBE NEWSWIRE) — Calian Group Ltd. […]
